Prediction of adverse health effects at altitude or during air travel is relevant, particularly in
pre-existing cardiopulmonary disease such as pulmonary arterial or chronic thromboembolic …

BACKGROUND: Recent air travel recommendations suggest patients with precapillary
pulmonary hypertension (PCPH) in New York Heart Association (NYHA) functional class 3 …

Commercial aircraft flight represents a highly variable altitude exposure that may result in
significant hypoxemia for patients with cardiac or pulmonary disease. To develop better …

At the present time, commercial aircraft cabins are required to be pressurized to the
equivalent of 8,000 feet or less. Although in-flight medical emergencies are infrequent, some …

More than 140 million people are living at high altitude worldwide. An increase of pulmonary
artery pressure (PAP) is a hallmark of high-altitude exposure and, if pronounced, may be …

Background There is insufficient evidence to counsel patients with pulmonary hypertension
undergoing altitude or air travel. We thus aimed to study hemodynamic response of patients …

Abstract Matthias Peter Hilty, Andrea Mueller, Daniela Flück, Christoph Siebenmann, Peter
Rasmussen, Stefanie Keiser, Katja Auinger, Carsten Lundby, and Marco Maggiorini. Effect …

Abstract Luks, Andrew M. Can patients with pulmonary hypertension travel to high altitude?
High Alt. Med. Biol. 10: 215–219, 2009.—With the increasing popularity of adventure travel …

The reduced pressure in an aircraft cabin may cause significant hypoxaemia and respiratory
symptoms in patients with chronic obstructive pulmonary disease (COPD). The current study …

Hypoxemia occurs during air travel because the pressure in aircraft cabins is not maintained
equal to barometric pressure at sea level. Identification of patients who will develop …